Xometry (NASDAQ:XMTR) Releases Earnings Results, Beats Estimates By $0.04 EPS

Xometry (NASDAQ:XMTR) issued its earnings results on Tuesday. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.04, Briefing.com reports. Xometry had a negative return on equity of 5.45% and a negative net margin of 8.99%.The business had revenue of $192.40 million during the quarter, compared to analyst estimates of $183.37 million. During the same quarter in the prior year, the firm earned $0.06 earnings per share. Xometry’s revenue for the quarter was up 29.5% on a year-over-year basis.

Here are the key takeaways from Xometry’s conference call:

• Record Q4 and full-year 2025 — Q4 revenue exceeded $192M (+30% YoY), marketplace gross margin was 35.3%, and full-year adjusted EBITDA was $18.5M, showing accelerating revenue growth and profitability.
• Management outlook calls for Q1 revenue of $187–189M (24–25% YoY) and at least 21% revenue growth for 2026, with expectations for higher marketplace gross margins and at least 20% incremental adjusted EBITDA margins for the year.
• Leadership transition announced — founder Randy Altschuler will become executive chair and President Sanjiv Singh Sahni will be CEO effective July 1, 2026; Randy will remain the largest individual shareholder and active strategic lead.
• Product- and enterprise-led momentum — AI features (auto quotes for injection molding, enhanced AI DFM), Teamspace (11,000+ teams), Workcenter supplier app, and ERP/PunchOut integrations are driving marketplace expansion and larger-account adoption (4 accounts > $10M, 140 accounts > $500K).
• International and services headwinds remain — international posted a Q4 adjusted EBITDA loss ($2.4M) and services/Thomas revenue is roughly flat during the Thomas ad/search transition, exposing areas that need improvement amid macro uncertainty.

Xometry Stock Down 5.9%

Shares of Xometry stock opened at $41.82 on Thursday. The company has a quick ratio of 3.58, a current ratio of 3.62 and a debt-to-equity ratio of 1.20. The company has a market cap of $2.14 billion, a P/E ratio of -34.28 and a beta of 0.86. Xometry has a 52-week low of $18.59 and a 52-week high of $73.87. The firm’s 50 day moving average price is $61.34 and its 200-day moving average price is $56.11.

Xometry News Summary

Here are the key news stories impacting Xometry this week:

• Positive Sentiment: Q4 results beat expectations — Xometry reported EPS of $0.16 (vs. $0.12 consensus) and revenue of $192.4M, +29.5% year-over-year, evidence of durable top-line growth. This is the main fundamental positive driving investor interest today. Zacks: Q4 Earnings
• Positive Sentiment: Management set a 2026 target of at least ~21% revenue growth and emphasized expanding enterprise adoption; that forward growth guide supports the company’s growth story despite current unprofitable margins. Seeking Alpha: 2026 Guidance
• Neutral Sentiment: Xometry announced a CEO succession plan — a planned leadership transition that management frames as orderly; outcome depends on execution and may be neutral-to-positive over time if the new leader sustains growth. Yahoo Finance: CEO Succession
• Neutral Sentiment: UBS nudged its price target slightly higher to $55 and kept a neutral rating, signaling cautious confidence but not a clear buy signal to the market. AmericanBankingNews: UBS PT
• Negative Sentiment: Wedbush cut its price target to $60 (from $70) while keeping an outperform rating — a downward reprice that reduces upside expectations and likely pressured the stock. AmericanBankingNews: Wedbush PT
• Negative Sentiment: Royal Bank of Canada trimmed its target to $55 (from $64) and moved to sector perform, another cut that contributes to negative analyst sentiment. AmericanBankingNews: RBC PT
• Negative Sentiment: Citigroup lowered its target to $65 (from $75) though it retained a buy rating — a mixed signal that still reduces consensus upside and likely weighed on the stock. AmericanBankingNews: Citigroup PT

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. UBS Group boosted their target price on Xometry from $54.00 to $55.00 and gave the company a “neutral” rating in a research note on Wednesday. JPMorgan Chase & Co. upped their price objective on Xometry from $55.00 to $70.00 and gave the company an “overweight” rating in a research report on Wednesday, November 5th. Citigroup dropped their price objective on Xometry from $75.00 to $65.00 and set a “buy” rating on the stock in a research report on Wednesday. Royal Bank Of Canada lowered their target price on Xometry from $64.00 to $55.00 and set a “sector perform” rating on the stock in a report on Wednesday. Finally, The Goldman Sachs Group raised their target price on shares of Xometry from $49.00 to $56.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Five equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $62.00.

Insider Activity at Xometry

In other Xometry news, CEO Randolph Altschuler sold 14,826 shares of Xometry stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $66.53, for a total transaction of $986,373.78. Following the completion of the sale, the chief executive officer directly owned 295,445 shares in the company, valued at approximately $19,655,955.85. The trade was a 4.78% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Subir Dutt sold 2,500 shares of Xometry stock in a transaction dated Monday, February 9th. The shares were sold at an average price of $70.00, for a total value of $175,000.00. Following the transaction, the insider owned 64,919 shares of the company’s stock, valued at $4,544,330. The trade was a 3.71% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 63,861 shares of company stock worth $4,213,697 in the last 90 days. 9.66% of the stock is owned by insiders.

Hedge Funds Weigh In On Xometry

A number of large investors have recently bought and sold shares of the business. T. Rowe Price Investment Management Inc. acquired a new stake in Xometry in the 4th quarter valued at $15,938,000. Fuller & Thaler Asset Management Inc. acquired a new position in Xometry during the fourth quarter worth about $76,393,000. XTX Topco Ltd acquired a new stake in shares of Xometry in the fourth quarter valued at approximately $1,440,000. Numerai GP LLC raised its holdings in shares of Xometry by 24.7% during the 4th quarter. Numerai GP LLC now owns 7,510 shares of the company’s stock worth $447,000 after acquiring an additional 1,487 shares during the period. Finally, Odyssean LLC acquired a new position in Xometry in the 4th quarter valued at about $663,000. Institutional investors and hedge funds own 97.31% of the company’s stock.

Xometry Company Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.